Bakulev, A. L.

Issue Section Title Abstract File
Vol 90, No 1 (2014) DRUG TREATMENT IN DERMATOVENEROLOGY Long-term therapy of severe acne: selection of doses and administration schemes for systemic isotretinoin Abstract PDF
(Rus)
Vol 90, No 4 (2014) CLINICAL CASES A case of a combination of Crocker - Adamson follicular spinulosa, lichen acuminatus and Little - Lassueur syndrome Abstract PDF
(Rus)
Vol 91, No 1 (2015) SCIENTTIFIC RESEARCHES Endothelial dysfunction and its treatment in psoriasis patients Abstract PDF
(Rus)
Vol 91, No 1 (2015) DRUG TREATMENT IN DERMATOVENEROLOGY Microbial eczema: up-to-date topical treatment with silver sulfathiazole Abstract PDF
(Rus)
Vol 92, No 3 (2016) CLINICAL CASES A case of localized bullous scleroderma Abstract PDF
(Rus)
Vol 92, No 3 (2016) DRUG TREATMENT IN DERMATOVENEROLOGY Using clobetasol propionate in the form of a shampoo for the treatment of patients suffering from psoriasis localized in the scalp area Abstract PDF
(Rus)
Vol 92, No 5 (2016) GUIDELINES FOR PRACTITIONERS Strategy “treat to target” for patients with psoriasis. Relevant issues to biological therapy persistence Abstract PDF
(Rus)
Vol 92, No 5 (2016) DRUG TREATMENT IN DERMATOVENEROLOGY Selective intracellular inhibition of signalling pathways - new direction in systematic treatment of psoriasis patients Abstract PDF
(Rus)
Vol 93, No 1 (2017) SCIENTTIFIC RESEARCHES Methotrexate: Revisited efficiency and safety of drug administration in psoriasis patients Abstract PDF
(Rus)
Vol 93, No 5 (2017) SCIENTTIFIC RESEARCHES Efficacy and Safety of BCD-085, a Novel Interleukin-17 Inhibitor. Results of Phase II Clinical Trial in Patients with Moderate-to-Severe Plaque Psoriasis Abstract PDF
(Rus)
Vol 94, No 3 (2018) DRUG TREATMENT IN DERMATOVENEROLOGY Psoriasis: clinical and epidemiological features and therapy issues Abstract PDF
(Rus)
Vol 94, No 5 (2018) LITERATURE REVIEW Evolution of the understanding of psoriasis and therapeutic approaches used to manage such patients. BCD-085 is the first Russian genetically-engineered biological preparation for the treatment of patients suffering from psoriasis Abstract PDF
(Rus)
Vol 95, No 2 (2019) SCIENTTIFIC RESEARCHES Netakimab — new IL-17а inhibitor: 12-week results of phase III clinical study BCD-085-7/PLANETA in patients with moderate-tosevere plaque psoriasis Abstract PDF
(Rus)
Vol 95, No 3 (2019) DRUG TREATMENT IN DERMATOVENEROLOGY Long-term efficacy and safety of netakimab in patients with moderate-to-severe psoriasis. Results of phase II open-label extension clinical study BCD-085-2-ext Abstract PDF
(Rus)
Vol 95, No 4 (2019) GUIDELINES FOR PRACTITIONERS Dermatoscopy in the diagnosis of pigmented nevi Abstract PDF
(Rus)
Vol 95, No 4 (2019) DRUG TREATMENT IN DERMATOVENEROLOGY Results of the long-term observational noninterventional prospective study BODYGUARD in psoriasis patients Abstract PDF
(Rus)
Vol 95, No 5 (2019) DRUG TREATMENT IN DERMATOVENEROLOGY Certolizumab pegol: new opportunities for treatment of moderate to severe plaque psoriasis Abstract PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies